AGA living guideline recommends patients start advanced therapies early in their disease course rather than gradual step-up treatment approach. “Since the first biologic treatment for ulcerative ...

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis, published in Gastroenterology. This ...

What Does Treatment Failure Mean if You Have Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, defines what constitutes ulcerative colitis treatment ...

Oral small-molecule therapies are redefining first-line treatment in moderate to severe ulcerative colitis (UC) by offering noninfusion alternatives with rapid onset and high efficacy. Etrasimod, a ...

A medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings of a global study led by University of Chicago ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Living with ulcerative colitis means navigating a complex and often unpredictable digestive condition that impacts daily life in profound ways. This inflammatory bowel disease affects approximately 1 ...

EEN is primarily used for Crohn's disease, but its effectiveness in ulcerative colitis is unclear, necessitating further research. A systematic review analyzed 70 studies, finding no significant ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

Ulcerative colitis (UC) is a chronic immune-mediated idiopathic inflammatory disorder characterized by colonic inflammation which typically begins in the rectum and extends proximally. The disease ...